NTI164

Cannabis Stock Roundup: Avecho Surpasses Enrolment Target, Argent Ships CannEpil to Ireland, Neurotech Addresses Funding Queries

Finance

Cannabis Stock Roundup: Avecho Surpasses Enrolment Target, Argent Ships CannEpil to Ireland, Neurotech Addresses Funding Queries

April 29, 2026

Neurotech's Autism Trial Data Meets Regulatory Registration Threshold Ahead of Phase III Launch

Medical

Neurotech's Autism Trial Data Meets Regulatory Registration Threshold Ahead of Phase III Launch

March 25, 2026

Vitura Partners with MedReleaf Australia; Neurotech Opens First Phase 3 Autism Trial Site

Medical

Vitura Partners with MedReleaf Australia; Neurotech Opens First Phase 3 Autism Trial Site

March 17, 2026

Epsilon Healthcare Creates Biotech Unit; LGP Offloads WA Site for $7.8m; Neurotech Teams Up with University of Sydney on Rett Syndrome Research

Medical

Epsilon Healthcare Creates Biotech Unit; LGP Offloads WA Site for $7.8m; Neurotech Teams Up with University of Sydney on Rett Syndrome Research

February 18, 2026

Company Roundup: Avecho, InhaleRx, Neurotech, Peak, Zelira, Argent

Finance

Company Roundup: Avecho, InhaleRx, Neurotech, Peak, Zelira, Argent

February 02, 2026

Wentzel receives US healthcare honour; Neurotech publishes NTI164 trial data

Medical

Wentzel receives US healthcare honour; Neurotech publishes NTI164 trial data

January 19, 2026

Provocatus Elevates Luke Gartner to Managing Director; Nurotech Secures FDA Pediatric Designation

Medical

Provocatus Elevates Luke Gartner to Managing Director; Nurotech Secures FDA Pediatric Designation

October 08, 2025

Neurotech Opens Authorised Prescriber Pathway for Children's Cannabinoid Drug NTI164

Medical

Neurotech Opens Authorised Prescriber Pathway for Children's Cannabinoid Drug NTI164

September 24, 2025

US Cannabis Specialist Dr Bonni Goldstein Takes Chief Medical Advisor Role at Neurotech International

Medical

US Cannabis Specialist Dr Bonni Goldstein Takes Chief Medical Advisor Role at Neurotech International

June 16, 2025

Neurotech's paediatric cannabinoid drug NTI164 clears first human PK study with positive absorption data

Medical

Neurotech's paediatric cannabinoid drug NTI164 clears first human PK study with positive absorption data

June 03, 2025

Finance

Industry Roundup: InhaleRx, Hemp Pet, Neurotech International, Cann Group

November 19, 2024

Medical

FDA Turns Down Neurotech's Orphan Drug Bid for Paediatric Neurological Treatment

October 08, 2024

Neurotech Eyes Global Pharma Partnerships for NTI164 While Keeping Australian Rights In-House

Finance

Neurotech Eyes Global Pharma Partnerships for NTI164 While Keeping Australian Rights In-House

August 12, 2024

Cannabinoid Developer in Productive TGA Discussions as ARTG Fast-Track Path Comes Into Focus

Medical

Cannabinoid Developer in Productive TGA Discussions as ARTG Fast-Track Path Comes Into Focus

June 28, 2024

Neurotech Secures A$10m Raise as Autism and Rett Syndrome Drug Trials Show Positive Outcomes

Medical

Neurotech Secures A$10m Raise as Autism and Rett Syndrome Drug Trials Show Positive Outcomes

April 17, 2024

NTI164 Cannabinoid Therapy Shows Promising Phase I/II Trial Outcomes in Children with PANDAS and PANS

Medical

NTI164 Cannabinoid Therapy Shows Promising Phase I/II Trial Outcomes in Children with PANDAS and PANS

October 06, 2023